New treatment modalities and pharmacologic refinements for metatstatic breast cancer
In this thesis the results of clinical studies with new chemotherapeutic agents and pharmacokinetic studies on taxanes in breast cancer patients are reported. In metastatic breast cancer, endocrine and cytotoxic treatment often result in objective tumor responses, associated with relevant relief of symptoms. At present, however, metastatic breast cancer is still considered to be incurable even despite agressive multi-modality treatment options. Chemotherapy for metastatic breast cancer should therefore aim at a maximum of palliation and prolongation of life, at the cost of a minimal of toxicity.
|Keywords||Anthracyclines, breast cancer, pharmacokinetics, taxanes|
|Promotor||Verweij, J. (Jaap)|
|Publisher||Erasmus MC: University Medical Center Rotterdam|
Smorenburg, C.H.. (2002, June 21). New treatment modalities and pharmacologic refinements for metatstatic breast cancer. Erasmus MC: University Medical Center Rotterdam. Retrieved from http://hdl.handle.net/1765/31948